000 01562 a2200397 4500
005 20250516203104.0
264 0 _c20150519
008 201505s 0 0 eng d
022 _a1559-0267
024 7 _a10.1007/s12016-014-8413-3
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aZhang, Cheng
245 0 0 _aInhibition of the interleukin-6 signaling pathway: a strategy to induce immune tolerance.
_h[electronic resource]
260 _bClinical reviews in allergy & immunology
_cOct 2014
300 _a163-73 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 0 4 _aAntibodies, Monoclonal
_xtherapeutic use
650 0 4 _aAutoimmune Diseases
_xdrug therapy
650 0 4 _aAutoimmunity
_xgenetics
650 0 4 _aCell Differentiation
650 0 4 _aGene Expression Regulation
_ximmunology
650 0 4 _aGraft Rejection
_xprevention & control
650 0 4 _aHumans
650 0 4 _aImmune Tolerance
_xdrug effects
650 0 4 _aImmunologic Factors
_xtherapeutic use
650 0 4 _aInterleukin-6
_xantagonists & inhibitors
650 0 4 _aLymphocyte Activation
650 0 4 _aReceptors, Interleukin-6
_xantagonists & inhibitors
650 0 4 _aSignal Transduction
650 0 4 _aT-Lymphocytes, Regulatory
_ximmunology
650 0 4 _aTh17 Cells
_ximmunology
700 1 _aZhang, Xi
700 1 _aChen, Xing-Hua
773 0 _tClinical reviews in allergy & immunology
_gvol. 47
_gno. 2
_gp. 163-73
856 4 0 _uhttps://doi.org/10.1007/s12016-014-8413-3
_zAvailable from publisher's website
999 _c23656819
_d23656819